DOLPHIN MEDICAL SERVICES LTD.

NSE : NABSE : 526504ISIN CODE : INE796B01013Industry : Hospital & Healthcare ServicesHouse : Private
BSE2.300 (0 %)
PREV CLOSE ( ) 2.30
OPEN PRICE ( ) 2.30
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 2.30 (49834)
VOLUME 557
TODAY'S LOW / HIGH ( )2.30 2.30
52 WK LOW / HIGH ( ) 1.363.25
NSE
This Company is not listed in NSE
( in Million)
Select year
ParticularsMar2016Mar2015Mar2014Mar2013Mar2012
Profit Before Tax-0.46-5.75-8.65-19.78-14.90
Adjustment3.925.557.6013.5423.62
Changes In working Capital-4.670.652.867.453.84
Cash Flow after changes in Working Capital-1.220.461.811.2112.56
Cash Flow from Operating Activities-1.220.461.851.5312.99
Cash Flow from Investing Activities0.13NA-1.71-1.18-4.95
Cash Flow from Financing Activities1.09-0.48-0.18-0.32-8.82
Net Cash Inflow / Outflow0.00-0.03-0.040.02-0.78
Opening Cash & Cash Equivalents0.070.100.140.110.89
Cash & Cash Equivalent on Amalgamation / Take over / MergerNANANANANA
Cash & Cash Equivalent of Subsidiaries under liquidationsNANANANANA
Translation adjustment on reserves / op cash balalces frgn subsidiariesNANANANANA
Effect of Foreign Exchange FluctuationsNANANANANA
Closing Cash & Cash Equivalent0.070.070.100.140.11

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.